Assessment of Bleeding Risk and Cerebrovascular Events in Bipolar Disorder Patients With Atrial Fibrillation on Warfarin Versus Rivaroxaban

No abstract available
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research